NON SMALL CELL LUNG CANCER STAGE III
Clinical trials for NON SMALL CELL LUNG CANCER STAGE III explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER STAGE III trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo may help more lung cancer patients get Life-Extending radiation
Disease control TerminatedThis study tested whether adding the immunotherapy drug durvalumab to standard chemotherapy could shrink large stage III lung tumors enough to allow patients to then receive radiation therapy. The trial was stopped early after enrolling only 10 people, so results are limited. The…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Step counts could guide care for lung cancer patients
Symptom relief TerminatedThis study looked at whether monitoring daily step counts in people with advanced lung cancer during chemoradiotherapy could help doctors provide better supportive care and reduce problems like hospital stays or treatment delays. Only 3 people took part before the study was stopp…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Phase: NA • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 16, 2026 12:51 UTC